Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines

Biomaterials

Volumn 33, Issue 35, 2012, Pages 9037-9048

  Chandrasekaran, Siddarth ^a   Geng, Yue ^a   DeLouise, Lisa A ^b   King, Michael R ^a  

^a Cornell University   (United States)

^b University of Rochester   (United States)

Author keywords

3D; Breast cancer; Co culture; E selectin; PDMS; Tumor spheroid

Indexed keywords

3D; BREAST CANCER; COCULTURE; E-SELECTIN; PDMS; TUMOR SPHEROID;

ADHESION; BLOOD VESSELS; CELL PROLIFERATION; DISEASES; ENDOTHELIAL CELLS; MICROCHANNELS; MONOLAYERS; PATHOLOGY; SILICONES; THREE DIMENSIONAL COMPUTER GRAPHICS; TISSUE CULTURE; TUMORS;

CYTOLOGY;

DIMETICONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MATRIGEL; RECOMBINANT PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL ASSAY; CELL INTERACTION; CELL INVASION; CELL STRAIN MCF 7; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; SPHEROID CELL; THREE DIMENSIONAL IMAGING;

CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; DIMETHYLPOLYSILOXANES; E-SELECTIN; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; MCF-7 CELLS; PHENOTYPE; SPHEROIDS, CELLULAR; STROMAL CELLS;

EID: 84867139870     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.052     Document Type: Article

References (52)

1. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4(6):448-456.
2. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 1997, 14(5):577-584.
3. Zen K., Liu D.Q., Guo Y.L., Wang C., Shan J., Fang M., et al. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One 2008, 3(3):e1826.
4. Takada A., Ohmori K., Yoneda T., Tsuyuoka K., Hasegawa A., Kiso M., et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 1993, 53(2):354-361.
5. Hughes A.D., Mattison J., Western L.T., Powderly J.D., Greene B.T., King M.R. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clin Chem 2012, 58(5):846-853.
6. Rana K., Liesveld J.L., King M.R. Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin. Biotechnol Bioeng 2009, 102(6):1692-1702.
7. Hsu J.W., Yasmin-Karim S., King M.R., Wojciechowski J.C., Mickelsen D., Blair M.L., et al. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1alpha, 25-dihydroxyvitamin D3. Am J Pathol 2011, 178(2):872-880.
8. Hirschhaeuser F., Menne H., Dittfeld C., West J., Mueller-Klieser W., Kunz-Schughart L.A. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 2010, 148(1):3-15.
9. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989, 49(23):6449-6465.
10. Locasale J.W., Cantley L.C. Altered metabolism in cancer. BMC Biol 2010, 8:88.
11. Kim J.W., Dang C.V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006, 66(18):8927-8930.
12. Chandrasekaran S., DeLouise L.A. Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line. Biomaterials 2011, 32(35):9316-9327.
13. Polyak K. Heterogeneity in breast cancer. J Clin Invest 2011, 121(10):3786-3788.
14. Polyak K. Breast cancer: origins and evolution. J Clin Invest 2007, 117(11):3155-3163.
15. Greaves M., Maley C.C. Clonal evolution in cancer. Nature 2012, 481(7381):306-313.
16. Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science 2011, 331(6024):1559-1564.
17. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
18. Harlozinska A. Progress in molecular mechanisms of tumor metastasis and angiogenesis. Anticancer Res 2005, 25(5):3327-3333.
19. Elenbaas B., Weinberg R.A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001, 264(1):169-184.
20. Buess M., Nuyten D.S., Hastie T., Nielsen T., Pesich R., Brown P.O. Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer. Genome Biol 2007, 8(9):R191.
21. DeClerck Y.A. Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 2000, 36(10):1258-1268.
22. Repesh L.A. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989, 9(3):192-208.
23. Tong D., Czerwenka K., Sedlak J., Schneeberger C., Schiebel I., Concin N., et al. Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines. Breast Cancer Res Treat 1999, 56(1):91-97.
24. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007, 2(2):329-333.
25. Fu O.Y., Hou M.F., Yang S.F., Huang S.C., Lee W.Y. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells. Anticancer Res 2009, 29(8):3131-3138.
26. Mehlen P., Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006, 6(6):449-458.
27. Strell C., Entschladen F. Extravasation of leukocytes in comparison to tumor cells. Cell Commun Signal 2008, 6:10.
28. Geng Y., Marshall J.R., King M.R. Glycomechanics of the metastatic cascade: tumor cell-endothelial cell interactions in the circulation. Ann Biomed Eng 2012, 40(4):790-805.
29. Orr F.W., Wang H.H., Lafrenie R.M., Scherbarth S., Nance D.M. Interactions between cancer cells and the endothelium in metastasis. J Pathol 2000, 190(3):310-329.
30. Howell A. An early peak of relapse after surgery for breast cancer. Breast Cancer Res 2004, 6(6):255-257.
31. Charafe-Jauffret E., Ginestier C., Iovino F., Wicinski J., Cervera N., Finetti P., et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009, 69(4):1302-1313.
32. Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10(6):515-527.
33. Konstantopoulos K., Thomas S.N. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng 2009, 11:177-202.
34. Jeschke U., Mylonas I., Shabani N., Kunert-Keil C., Schindlbeck C., Gerber B., et al. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Anticancer Res 2005, 25(3A):1615-1622.
35. Kyselova Z., Mechref Y., Kang P., Goetz J.A., Dobrolecki L.E., Sledge G.W., et al. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem 2008, 54(7):1166-1175.
36. Narasipura S.D., Wojciechowski J.C., Charles N., Liesveld J.L., King M.R. P-Selectin coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow. Clin Chem 2008, 54(1):77-85.
37. Sun X.G., Rotenberg S.A. Overexpression of protein kinase Calpha in MCF-10A human breast cells engenders dramatic alterations in morphology, proliferation, and motility. Cell Growth Differ 1999, 10(5):343-352.
38. Giunciuglio D., Culty M., Fassina G., Masiello L., Melchiori A., Paglialunga G., et al. Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int J Cancer 1995, 63(6):815-822.
39. Turner N.C., Reis-Filho J.S. Genetic heterogeneity and cancer drug resistance. Lancet Oncol 2012, 13(4):e178-e185.
40. Kunz-Schughart L.A. Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int 1999, 23(3):157-161.
41. Poczobutt J.M., Tentler J., Lu X., Schedin P.J., Gutierrez-Hartmann A. Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells. BMC Cancer 2010, 10:373.
42. Heppner G.H., Miller F.R. The cellular basis of tumor progression. Int Rev Cytol 1998, 177:1-56.
43. Weigelt B., Peterse J.L., van 't Veer L.J. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005, 5(8):591-602.
44. Keith B., Simon M.C. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007, 129(3):465-472.
45. Hill R.P., Marie-Egyptienne D.T., Hedley D.W. Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol 2009, 19(2):106-111.
46. Rankin E.B., Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008, 15(4):678-685.
47. Calzada M.J., del Peso L. Hypoxia-inducible factors and cancer. Clin Transl Oncol 2007, 9(5):278-289.
48. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3(10):721-732.
49. Koike T., Kimura N., Miyazaki K., Yabuta T., Kumamoto K., Takenoshita S., et al. Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci U S A 2004, 101(21):8132-8137.
50. Weljie A.M., Jirik F.R. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect. Int J Biochem Cell Biol 2011, 43(7):981-989.
51. Shirato K., Nakajima K., Korekane H., Takamatsu S., Gao C., Angata T., et al. Hypoxic regulation of glycosylation via the N-acetylglucosamine cycle. J Clin Biochem Nutr 2011, 48(1):20-25.
52. Sakuma K., Aoki M., Kannagi R. Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 2012, 109(20):7776-7781.